Imbruvica seemed invincible in the marketplace. But a new book, “For Blood and Money,” shows how the drug’s creators left a trap door that led to its undoing.
You are here: Home / Top Stories / : One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.